T-Therapeutics
Operator of a biopharmaceutical company intended to develop engineered soluble biologics for oncological and immunological indications. The company's proprietary T cell receptors (TCR) discovery platf...
Valuation
$0
Share Price
N/A
Total Raised
$95M
Last Round
N/A